Travatan Z .04 mg/mL
travoprost · SOLUTION/ DROPS · Novartis Pharmaceuticals Corporation
Travatan Z is a solution/ drops containing travoprost at .04 mg/mL, taken ophthalmic. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Travatan Z
- Generic Name
- travoprost
- NDC Code (Product)
0078-0946- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- .04 mg/mL
- Dosage Form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- NDA021994
- Drug Class
- Prostaglandin Analog [EPC]
- Marketing Start
- 10/20/2006
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
1 INDICATIONS AND USAGE TRAVATAN Z ® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. TRAVATAN Z is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (1)
Dosage & Administration
2 DOSAGE AND ADMINISTRATION The recommended dosage is one drop in the affected eye(s) once daily in the evening. TRAVATAN Z should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the IOP-lowering effect. Reduction of the IOP starts approximately 2 hours after the first administration with maximum effect reached after 12 hours. TRAVATAN Z may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes apart. One drop in the affected eye(s) once daily in the evening (2)
Contraindications
4 CONTRAINDICATIONS None. None (4)
Adverse Reactions
6 ADVERSE REACTIONS Most common adverse reaction (30% to 50%) is conjunctival hyperemia (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most common adverse reaction observed in controlled clinical trials with TRAVATAN and TRAVATAN Z was ocular hyperemia, which was reported in 30% to 50% of patients. Up to 3% of patients discontinued therapy due to conjunctival hyperemia. Ocular adverse reactions, reported at an incidence of 5% to 10% in these clinical trials, included decreased visual acuity, eye discomfort, foreign body sensation, pain, and pruritus. Ocular adverse reactions, reported at an incidence of 1% to 4% in clinical trials with TRAVATAN or TRAVATAN Z, included abnormal vision, blepharitis, blurred vision, cataract, conjunctivitis, corneal staining, dry eye, iris discolor…
Frequently Asked Questions
What is Travatan Z used for?
Travatan Z contains travoprost. It is a solution/ drops taken ophthalmic. Consult your doctor for specific uses.
Is Travatan Z a controlled substance?
Travatan Z is not classified as a controlled substance by the DEA.
What is the generic name for Travatan Z?
The generic name for Travatan Z is travoprost. There are 11 other brand versions of travoprost.
What is the NDC code for Travatan Z .04 mg/mL?
The NDC (National Drug Code) for Travatan Z .04 mg/mL is 0078-0946, listed by Novartis Pharmaceuticals Corporation.
Other Travoprost Brands
See all →- Travoprost Ophthalmic Solution.04 mg/mL68083-602
- Travoprost Ophthalmic Soluton.04 mg/mL25021-002
- iDose TR75 ug/125357-100
- Travoprost.04 mg/mL51407-731
- Travoprost Ophthalmic.04 mg/mL72162-2432
- Travoprost Ophthalmic Solution USP, 0.004% Travoprost.04 mg/mL62332-510
- Travoprost Ophthalmic Solution.04 mg/mL68083-601
- Travoprost.04 mg/mL70069-586
- Travoprost ophthalmic solution.04 mg/mL46708-625
- Travoprost ophthalmic solution.04 mg/mL62332-625
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)